Ann: Proteomics bolsters executive team - CCO and CFO appointed, page-43

Hi Aruc,

Don’t worry, I do remember you. I have a genuine suggestion for you. Email the new CCO (Chief Commercialisation Officer) at PIQ with your questions.

Maybe also go through ANNs & threads here & look at all the research posted since you have been gone.

It’s really not a good look coming back here when the SP is getting hit hard & carrying on with all your concerns & demanding answers. You missed the boat on that run to $1.48, that was a shame for you (genuinely). It’s nothing unusual for this stock to fluctuate 7-10c on a daily basis AND on low volume. It’s June & possible that some who bought in higher getting out.

We are due on some FDA news very soon.

I’m pretty sure that Janssen don’t think PromarkerD is a dud - The research paper on PIQ/Janssen collaboration from Ph1 is actually cited in Janssen’s Prescriber Information for Canagliflozin (Invokana).

Yes we are waiting on data for Ph2 & Janssen to complete - the laboratory analysis on PIQ’s end is done, so maybe email the R&D Department at Janssen Global & ask them what Is taking so long? Lol!

Have a good night folks & back to the cooking.